These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Expression of biologically active human vascular endothelial growth factor in yeast. Mohanraj D, Olson T, Ramakrishnan S. Growth Factors; 1995; 12(1):17-27. PubMed ID: 8527160 [Abstract] [Full Text] [Related]
4. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. Gitay-Goren H, Soker S, Vlodavsky I, Neufeld G. J Biol Chem; 1992 Mar 25; 267(9):6093-8. PubMed ID: 1556117 [Abstract] [Full Text] [Related]
5. High levels of biologically active vascular endothelial growth factor (VEGF) are produced by the baculovirus expression system. Cohen T, Gitay-Goren H, Neufeld G, Levi BZ. Growth Factors; 1992 Mar 25; 7(2):131-8. PubMed ID: 1419070 [Abstract] [Full Text] [Related]
6. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Goto F, Goto K, Weindel K, Folkman J. Lab Invest; 1993 Nov 25; 69(5):508-17. PubMed ID: 8246443 [Abstract] [Full Text] [Related]
13. Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. Grugel S, Finkenzeller G, Weindel K, Barleon B, Marmé D. J Biol Chem; 1995 Oct 27; 270(43):25915-9. PubMed ID: 7592779 [Abstract] [Full Text] [Related]
14. The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation. Walter DH, Hink U, Asahara T, Van Belle E, Horowitz J, Tsurumi Y, Vandlen R, Heinsohn H, Keyt B, Ferrara N, Symes JF, Isner JM. Lab Invest; 1996 Feb 27; 74(2):546-56. PubMed ID: 8780172 [Abstract] [Full Text] [Related]
15. Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Myoken Y, Kayada Y, Okamoto T, Kan M, Sato GH, Sato JD. Proc Natl Acad Sci U S A; 1991 Jul 01; 88(13):5819-23. PubMed ID: 1712106 [Abstract] [Full Text] [Related]
16. [Therapeutic angiogenesis using genetic transfection. An in vitro quantitative and functional study after gene code transfer for vascular endothelial growth factor]. Zaric V, Weltin D, Stephan D. Arch Mal Coeur Vaiss; 2000 Aug 01; 93(8):987-91. PubMed ID: 10989743 [Abstract] [Full Text] [Related]
18. Vascular endothelial growth factor is inactivated by binding to alpha 2-macroglobulin and the binding is inhibited by heparin. Soker S, Svahn CM, Neufeld G. J Biol Chem; 1993 Apr 15; 268(11):7685-91. PubMed ID: 7681826 [Abstract] [Full Text] [Related]
20. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG. Proc Natl Acad Sci U S A; 1991 Oct 15; 88(20):9267-71. PubMed ID: 1924389 [Abstract] [Full Text] [Related] Page: [Next] [New Search]